Nephros, Inc. (NEPH) Financials

NEPH Assets vs Liabilities
DateAssetsLiabilities
March 31, 2026 13.8 million 3.1 million
Dec. 31, 2025 13.6 million 3.4 million
Sept. 30, 2025 13.2 million 3.2 million
June 30, 2025 12.2 million 2.6 million

NEPH Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
DateFree Cash FlowStock based compensation
March 31, 2026 -1.7 million 60000
Dec. 31, 2025 230000 79000
Sept. 30, 2025 99000 70000
June 30, 2025 994000 71000

NEPH Net Income

No data available :(

NEPH Cash and Debt
Graph available only for paid members. Upgrade to see it.
DateCashDebtCapital Lease
March 31, 2026 4.0 million 566000 -
Dec. 31, 2025 5.4 million - 672000
Sept. 30, 2025 5.2 million - 1.2 million
June 30, 2025 5.1 million - 1.2 million

NEPH Shares Outstanding
Graph available only for paid members. Upgrade to see it.
DateShares Outstanding
March 31, 2026 11.0 million
Dec. 31, 2025 11.0 million
Sept. 30, 2025 11.0 million
June 30, 2025 10.8 million

NEPH Expenses
Graph available only for paid members. Upgrade to see it.
DateCapexR&DG&AS&M
March 31, 2026 - 346000 2.5 million -
Dec. 31, 2025 - 395000 2.3 million -
Sept. 30, 2025 - 338000 2.2 million -
June 30, 2025 - 311000 2.2 million -

NEPH Cost of Revenue
Graph available only for paid members. Upgrade to see it.
DateRevenueCost of Revenue
March 31, 2026 5.2 million 2.2 million
Dec. 31, 2025 4.7 million 2.1 million
Sept. 30, 2025 4.8 million 1.8 million
June 30, 2025 4.4 million 1.6 million

NEPH Revenue by Segment
Graph available only for paid members. Upgrade to see it.

NEPH

Price: $3.42

52 week price:
2.66
6.42

Payout Ratio Range:
-2909.09%
-6.99%

Earnings Per Share: 0.08 USD

P/E Ratio: 44.38

Exchange: NCM

Sector: Healthcare

Industry: Medical Instruments & Supplies

Country: United States

Volume: 13441

Market Capitalization: 39.1 million

Links: